By using this site, you agree to the Privacy Policy and Terms of Use.
Accept
GMJ NewsGMJ NewsGMJ News
  • Latest News
    • GMJ Briefs
  • Podcast & Media
    • Podcast Episodes
    • GMJ Audio
    • GMJ Videos
  • Research Digest
    • New Studies
    • Georgian Research
    • Data & Numbers
  • Policy & Systems
    • Health Policy
    • Quality & Safety
    • Migration & Health
    • Global Health
  • Practice
    • Clinical Updates
    • Case Discussions
    • Pharmacy & Prescribing
    • Ingredients A-Z
  • Perspectives
    • Editorial
    • Explainers
    • Voices
    • Letters
  • GMJ Articles
    • Vol. 1 Issue 2 (2026)
    • Vol. 1 Issue 1 (2026)
    • Pre-Launch Articles (2025)
  • Read the Journal →
  • About GMJ News
Notification Show More
Font ResizerAa
GMJ NewsGMJ News
Font ResizerAa
  • Latest News
    • GMJ Briefs
  • Podcast & Media
    • Podcast Episodes
    • GMJ Audio
    • GMJ Videos
  • Research Digest
    • New Studies
    • Georgian Research
    • Data & Numbers
  • Policy & Systems
    • Health Policy
    • Quality & Safety
    • Migration & Health
    • Global Health
  • Practice
    • Clinical Updates
    • Case Discussions
    • Pharmacy & Prescribing
    • Ingredients A-Z
  • Perspectives
    • Editorial
    • Explainers
    • Voices
    • Letters
  • GMJ Articles
    • Vol. 1 Issue 2 (2026)
    • Vol. 1 Issue 1 (2026)
    • Pre-Launch Articles (2025)
  • Read the Journal →
  • About GMJ News
Follow US
GMJ News > Drugs A-Z > General > Oxcarbazepine

Oxcarbazepine

GMJ
Last updated: 02/06/2026 14:30
By
Prof. Giorgi Pkhakadze
Share
4 Min Read
SHARE
3 min read|580 words

Oxcarbazepine: Drug Profile and Safety Information

What is Oxcarbazepine?

Oxcarbazepine is an anticonvulsant medication belonging to the class of antiepileptic drugs (AEDs). It is primarily used to treat epilepsy and seizure disorders, helping to prevent and control various types of seizures. This medication is chemically related to carbamazepine but has a different metabolic profile and may cause fewer drug interactions.

Uses

Oxcarbazepine has several approved and documented medical uses:

  • Partial seizures: Primary indication for treating focal seizures with or without secondary generalization in adults and children
  • Generalized tonic-clonic seizures: Effective for managing primary generalized seizures
  • Bipolar disorder: Used off-label as a mood stabilizer when other treatments are not suitable or effective
  • Trigeminal neuralgia: Alternative treatment for facial nerve pain when carbamazepine is not tolerated
  • Neuropathic pain: Off-label use for various chronic pain conditions involving nerve damage

How it works

Oxcarbazepine works by blocking voltage-sensitive sodium channels in nerve cell membranes, which prevents the rapid firing of neurons that can lead to seizures. By stabilizing the electrical activity in the brain, it reduces the likelihood of abnormal electrical discharges that cause epileptic seizures. The medication also affects calcium channels and may influence neurotransmitter release, contributing to its anticonvulsant effects.

Side effects

Common side effects include:

Submit Your Paper
GMJ_Submit_Banner
  • Dizziness and drowsiness
  • Nausea and vomiting
  • Headache
  • Fatigue and weakness
  • Double vision or blurred vision
  • Tremor
  • Coordination problems
  • Abdominal pain

Serious side effects to watch for:

  • Severe skin reactions (Stevens-Johnson syndrome, toxic epidermal necrolysis)
  • Low sodium levels (hyponatremia) causing confusion, seizures, or coma
  • Severe allergic reactions with fever, swollen lymph nodes, and organ involvement
  • Suicidal thoughts or behavior changes
  • Severe dizziness leading to falls

Warnings and precautions

  • Pregnancy considerations: Classified as pregnancy category C; may cause fetal harm and requires careful risk-benefit evaluation during pregnancy
  • Kidney function: Dose adjustments needed in patients with severe kidney impairment as the active metabolite is eliminated through the kidneys
  • Allergic reactions: Patients allergic to carbamazepine have a 25-30% risk of cross-reactivity with oxcarbazepine
  • Sodium monitoring: Regular blood tests needed to check sodium levels, especially in elderly patients and those taking diuretics
  • Withdrawal concerns: Should not be stopped abruptly as this may trigger seizures; requires gradual dose reduction under medical supervision

Interactions

Oxcarbazepine has several important drug interactions:

  • Oral contraceptives: Reduces effectiveness of hormonal birth control by increasing metabolism
  • Phenytoin: May increase phenytoin levels, requiring dose adjustments and monitoring
  • Carbamazepine: Can decrease oxcarbazepine levels while increasing carbamazepine toxicity risk
  • Warfarin: May alter anticoagulation effects requiring more frequent INR monitoring
  • Diuretics: Increased risk of low sodium levels when combined with water pills
  • Alcohol: Enhances sedative effects and may worsen coordination problems
  • Lamotrigine: May require dose adjustments of both medications
  • Calcium channel blockers: Oxcarbazepine may reduce levels of these heart medications

Check interactions with the GMJ Interaction Checker

Dosage

Typical adult dosing ranges from 300-600 mg twice daily, with treatment usually starting at a lower dose and gradually increasing. The maximum recommended daily dose is generally 2400 mg per day, divided into two doses. Initial treatment often begins with 300 mg twice daily, increasing by 300 mg every three days until an effective dose is reached. Pediatric dosing is weight-based and requires careful calculation by a healthcare provider. All dosage adjustments should be made gradually and under medical supervision, with individual patient response and tolerance determining the optimal therapeutic dose.

Sources: FDA DailyMed drug labels (public domain), BNF, WHO Essential Medicines List. This article is for informational purposes only and does not constitute medical advice. Always consult your healthcare provider before starting or stopping any medication.

Cite this page

GMJ News Desk. "Oxcarbazepine." GMJ News — Georgian Medical Journal, 2 June 2026. https://news.gmj.ge/drug/oxcarbazepine/

CC BY 4.0This work is licensed under Creative Commons Attribution 4.0 International (CC BY 4.0). You are free to share and adapt this content with attribution to GMJ News (news.gmj.ge).

Was this article helpful?

Share This Article
Facebook LinkedIn Bluesky Copy Link Print
GMJ
ByProf. Giorgi Pkhakadze
Follow:
Prof. Giorgi Pkhakadze, MD, MPH, PhD, is Editor-in-Chief of the Georgian Medical Journal and Chair of the Public Health Institute of Georgia (PHIG). He is Professor and Head of the Department of Social and Behavioural Sciences at David Tvildiani Medical University, and Secretary/Treasurer of the UEMS Section of Public Health. ORCID: 0000-0001-7609-4515.

Submit Your Paper →

Georgia's peer-reviewed open-access medical journal. No APC until January 2027.
Submit Manuscript →
Revolution Medicines Ships Experimental Pancreatic Cancer Drug Under Early Access

Revolution Medicines begins expanded access program for daraxonrasib targeting KRAS G12C mutations.…

NHS Patient Watchdog Abolition Sparks Concerns Over Health Service Accountability

Local councils warn that government plans to abolish NHS patient watchdogs will…

DNA Test Could Spare 6,600 Breast Cancer Patients From Unnecessary Chemotherapy

New genetic testing could spare 6,600 UK breast cancer patients annually from…

Submit Your Paper to GMJ

No APC until January 2027.
Submit Manuscript →

You Might Also Like

Magnesium supplements

By
Prof. Giorgi Pkhakadze
02/06/2026

Mycophenolate

By
Prof. Giorgi Pkhakadze
02/06/2026

Metoclopramide

By
Prof. Giorgi Pkhakadze
02/06/2026

Acetaminophen

By
Prof. Giorgi Pkhakadze
02/06/2026
Facebook Twitter Youtube Instagram
Company
  • Privacy Policy
  • Contact US
  • GMJ Journal
  • Submit Manuscript
  • Editorial Team
  • Register at GMJ
  • Terms of Use

Subscribe to GMJ News — Click here

Join Community
© 2026 Georgian Medical Journal (GMJ). Published by the Public Health Institute of Georgia (PHIG). All rights reserved.
Welcome Back!

Sign in to your account

Username or Email Address
Password

Lost your password?

Not a member? Sign Up